Table 3 Distribution of expression of ER and PR in metastatic mucinous carcinomas involving the ovary
Origin | ER a | PR a | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
0 | 1+ | 2+ | 3+ | 4+ | 0 | 1+ | 2+ | 3+ | 4+ | |
Colorectal (n=24) | 24 (100%) | 0 | 0 | 0 | 0 | 24 (100%) | 0 | 0 | 0 | 0 |
Unknown (n=15) | 15 (100%) | 0 | 0 | 0 | 0 | 15 (100%) | 0 | 0 | 0 | 0 |
Pancreatic (n=13) | 13 (100%) | 0 | 0 | 0 | 0 | 13 (100%) | 0 | 0 | 0 | 0 |
Endocervical (n=8) | 5 (63%) | 1b (13%) | 1b (13%) | 0 | 1b (13%) | 8 (100%) | 0 | 0 | 0 | 0 |
Gastric (n=4) | 4 (100%) | 0 | 0 | 0 | 0 | 4 (100%) | 0 | 0 | 0 | 0 |
Gallbladder/biliary tract (n=4) | 4 (100%) | 0 | 0 | 0 | 0 | 4 (100%) | 0 | 0 | 0 | 0 |
Appendiceal (n=4) | 4 (100%) | 0 | 0 | 0 | 0 | 4 (100%) | 0 | 0 | 0 | 0 |